BioVie Inc Warrant
BIVIW
9 hedge funds and large institutions have $596K invested in BioVie Inc Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and closing their positions.
143.1% more ownership
Funds ownership: 406.18% → 549.28% (+143%)
13% more funds holding
Funds holding: 8 → 9 (+1)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
19% less capital invested
Capital invested by funds: $734K → $596K (-$138K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$164K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$59.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$107 |
| 4 |
Cerity Partners
New York
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Prelude Capital Management
New York
|
-$35K |
| 2 |
MA
MYDA Advisors
Woodmere,
New York
|
-$327 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$188 |
BIVIW Hedge Fund Activity: Q4 2025 in Review
9 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in BioVie Inc Warrant (BIVIW) for Q4 2025, worth a combined $596K — down 19% from $734K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIVIW positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $164K. The largest seller was Prelude Capital Management, cutting an estimated $35K.
- 9 institutional investors held BioVie Inc Warrant (BIVIW) as of Q4 2025, up from 8 in Q3 2025.
- Funds reported $596K of BioVie Inc Warrant stock for Q4 2025, down 19% quarter-over-quarter.
- 1 fund opened new BioVie Inc Warrant positions in Q4 2025 and 0 closed out, a net change of +1 holder.
- The largest BioVie Inc Warrant buyer in Q4 2025 was Armistice Capital, an estimated $164K added.
- The largest BioVie Inc Warrant seller in Q4 2025 was Prelude Capital Management, an estimated $35K sold.
Based on aggregated 13F filings for Q4 2025.